Teva Pharmaceutical Industries Ltd financial data

Symbol
TEVA on NYSE, TEVJF on OTC
Industry
Pharmaceutical Preparations
Location
Teva Pharmaceutical Industries Limited, 124 Dvora Hanevi'a St., Tel Aviv, Israel
State of incorporation
Israel
Fiscal year end
December 31
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (to 1/16/2001)
Latest financial report
10-Q - Q2 2024 - Jul 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 94.8 % -8.91%
Quick Ratio 31.6 % -10.2%
Debt-to-equity 499 % +11.7%
Return On Equity -6.1 % +77.6%
Return On Assets -1.07 % +80%
Operating Margin 5.38 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.13B shares +1.09%
Entity Public Float 8.38B USD +14.8%
Common Stock, Value, Issued 58M USD +1.75%
Weighted Average Number of Shares Outstanding, Basic 1.13B shares +1.16%
Weighted Average Number of Shares Outstanding, Diluted 1.13B shares +1.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16.3B USD +8.48%
Research and Development Expense 54M USD
Selling and Marketing Expense 2.45B USD +9.62%
General and Administrative Expense 1.12B USD -4.6%
Operating Income (Loss) 877M USD +99.2%
Nonoperating Income (Expense) -1.02B USD +0.49%
Income Tax Expense (Benefit) 606M USD +174%
Net Income (Loss) Attributable to Parent -452M USD +80.6%
Earnings Per Share, Basic -0.39 USD/shares +81.4%
Earnings Per Share, Diluted -0.39 USD/shares +81.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.26B USD -15.4%
Accounts Receivable, after Allowance for Credit Loss, Current 3.77B USD +6.41%
Inventory, Net 3.93B USD -4.43%
Other Assets, Current 517M USD +6.38%
Assets, Current 11.6B USD -3.77%
Deferred Income Tax Assets, Net 2B USD +26.3%
Property, Plant and Equipment, Net 5.57B USD -2.43%
Operating Lease, Right-of-Use Asset 358M USD -14.4%
Goodwill 16.5B USD -3.68%
Other Assets, Noncurrent 434M USD -2.03%
Assets 41.3B USD -4.09%
Employee-related Liabilities, Current 492M USD +9.09%
Liabilities, Current 13B USD +10.1%
Operating Lease, Liability, Noncurrent 281M USD -16.9%
Other Liabilities, Noncurrent 4.36B USD +6.4%
Liabilities 34.8B USD -2.07%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.88B USD -7.62%
Retained Earnings (Accumulated Deficit) -14.5B USD -3.22%
Stockholders' Equity Attributable to Parent 6.36B USD -9.83%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.56B USD -13.6%
Liabilities and Equity 41.3B USD -4.09%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.17B USD -31.1%
Net Cash Provided by (Used in) Financing Activities -2.27B USD -18.7%
Net Cash Provided by (Used in) Investing Activities 807M USD +1%
Common Stock, Shares Authorized 2.5B shares 0%
Common Stock, Shares, Issued 1.24B shares +0.98%
Common Stock, Par or Stated Value Per Share 0.1 ILS/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -412M USD -171%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.26B USD -15.4%
Deferred Tax Assets, Valuation Allowance 3.01B USD -2.05%
Deferred Tax Assets, Gross 1.81B USD +24.3%
Operating Lease, Liability 417M USD -5.66%
Payments to Acquire Property, Plant, and Equipment 119M USD -6.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -653M USD +70.7%
Lessee, Operating Lease, Liability, to be Paid 496M USD -8.66%
Property, Plant and Equipment, Gross 11.4B USD +1.16%
Operating Lease, Liability, Current 320M USD -8.31%
Lessee, Operating Lease, Liability, to be Paid, Year Two 98M USD +4.26%
Lessee, Operating Lease, Liability, to be Paid, Year One 116M USD 0%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three 80M USD +1.27%
Unrecognized Tax Benefits 651M USD +2.04%
Lessee, Operating Lease, Liability, to be Paid, Year Four 62M USD -6.06%
Additional Paid in Capital 27.8B USD +0.29%
Amortization of Intangible Assets 587M USD -9.27%